A Phase I Open Label Study to Evaluate the Safety and Tolerability of Biological E's Live Live, Attenuated Measles Rubella Vaccine (MR) in 4-5 year Old Healthy Children. - None
Latest Information Update: 08 Sep 2016
At a glance
- Drugs Measles and rubella virus vaccine (Primary)
- Indications Measles; Rubella
- Focus Adverse reactions
- Sponsors Biological E Limited
- 08 Sep 2016 New trial record